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Introduction
When tubulin dimers polymerize into microtubules (MTs), the 
C-terminal tails of tubulin become exposed to the outer surface 
of the tubules (Nogales et al., 1998), where they provide binding 
sites for several MT-associated proteins (MAPs) and molecular 
motors (Wang and Sheetz, 2000; Lakämper and Meyhofer, 
2005). The tubulin tails are subjected to various posttranslational 
modifications. One of them, polyglutamylation, adds variable 
numbers of glutamates to the C-terminal tails of tubulin (Eddé   
et al., 1990), and is specifically enriched on the MTs of neurons, 
centrioles, cilia, and of the mitotic spindle (Audebert et al., 1994; 
Mary et al., 1996; Bobinnec et al., 1998; Regnard et al., 1999; 
Fig. S1). As it increases the negative charge of MT tails, poly-
glutamylation could regulate the interactions of MAPs with 
MTs (for review see Verhey and Gaertig, 2007; Janke et al., 2008).
A group of proteins potentially regulated by polygluta-
mylation are the MT-severing enzymes katanin (McNally and 
Vale, 1993; Hartman et al., 1998) and spastin (Evans et al., 2005; 
Roll-Mecak and Vale, 2005), which belong to the family of AAA 
ATPases. One structural model of MT severing suggested that 
hexameric spastin rings seize the acidic tubulin tails and destabi-
lize the MT lattice by pulling on the tails (Roll-Mecak and Vale, 
2008). In the proposed structure, the sequence domain of spastin 
that binds the tubulin tails is positively charged, and could thus 
attract the negatively charged tubulin tails via electrostatic inter-
actions. Polyglutamylation, which can further increase these 
charges by adding glutamate side chains, was therefore suggested 
as a potential regulator of MT severing (for review see Roll-Mecak 
and McNally, 2010).
A first link between tubulin modifications and MT sever-
ing was provided by the mutagenesis of the C-terminal tails of 
 -tubulin in the protist Tetrahymena thermophila. Although the 
mutations conserved the overall negative charge of the tubulin 
tails, they abolished glutamylation and also glycylation, another 
tubulin polymodification that uses the same modification sites as 
glutamylation (Redeker et al., 1994). Expression of the nonmodi-
fiable tubulin resulted in defects in ciliary assembly and cytokine-
sis (Thazhath et al., 2002), a phenotype similar to that of a 
Tetrahymena strain deficient for the MT-severing enzyme katanin 
(Sharma et al., 2007). These experiments suggested a potential role 
for tubulin glutamylation or glycylation in katanin-mediated MT 
severing, but did not discriminate between the two modifications. 
P
osttranslational glutamylation of tubulin is present on 
selected subsets of microtubules in cells. Although the 
modification is expected to contribute to the spatial 
and temporal organization of the cytoskeleton, hardly any-
thing is known about its functional relevance. Here we 
demonstrate that glutamylation, and in particular the gen-
eration of long glutamate side chains, promotes the sever-
ing of microtubules. In human cells, the generation of long 
side  chains  induces  spastin-dependent  microtubule  dis-
assembly and, consistently, only microtubules modified by 
long glutamate side chains are efficiently severed by spas-
tin in vitro. Our study reveals a novel control mechanism for 
microtubule mass and stability, which is of fundamental im-
portance to cellular physiology and might have implica-
tions for diseases related to microtubule severing.
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if the regulation of MT severing by polyglutamylation is due to a 
regulation on the catalytic domain of spastin, we also investigated 
a truncated version of the enzyme that only contains domains es-
sential for severing activity (C389-spastin; Fig. S3; White et al., 
2007). Upon expression in HeLa cells, both the 58-kD and the 
C389-spastin completely disassembled MTs, which made it im-
possible to monitor their activation by polyglutamylation. To cir-
cumvent this problem, we tested different mutations that have 
previously been shown to decrease the severing activity of 
spastin. After introduction of the S359C mutation (61% activity; 
Roll-Mecak and Vale, 2005; Fig. S3) into the 58-kD spastin iso-
form, and of the D552N mutation (19% activity; Roll-Mecak and 
Vale, 2005; Fig. S3) into C389-spastin, both proteins induced MT 
severing only in a low percentage of the transfected HeLa cells. 
Co-expression of TTLL6 or TTLL11 together with either the mu-
tated 58-kD spastin (S359C) for 16 h (Fig. 2) or with the mutated 
C389-spastin (D552N) for 7 h (Fig. 3) significantly increased 
the number of cells with MT severing. In contrast, coexpres-
sion of TTLL4, TTLL5, or TTLL7 did not change the fre-
quency of MT severing in the transfected cells (Figs. 2 and 3). 
The observed severing must be due to the activation of the   
exogenously expressed spastin because endogenous spastin was 
not activated at these early time points after transfection of 
polyglutamylating enzymes. Furthermore, coexpression of ac-
tive TTLL6 or TTLL11 with enzymatically dead spastin did 
not induce MT disassembly (unpublished data). Together, these 
results indicate that the severing activity of spastin can be stim-
ulated by the addition of long glutamate side chains on MTs, 
and that the mechanism of this activation resides in a domain of 
the spastin protein that is directly involved in the catalysis of 
MT severing.
To test whether spastin is directly activated by polyglutam-
ylation, we set up an in vitro MT severing assay using the trun-
cated version of spastin (C389-spastin; Fig. S3). MTs used in most 
published in vitro studies are highly polyglutamylated, as they 
are prepared from brain tubulin (Eddé et al., 1990). Because we 
wanted to test the role of polyglutamylation on spastin-mediated   
MT severing, MTs with very low glutamylation levels were 
purified from HeLa cells. With this as a reference, we also pre-
pared differentially glutamylated tubulin by transfecting HeLa 
cells 24 h before the tubulin purification with either TTLL4 or 
TTLL6. To visualize the MTs, we copolymerized the differently 
modified HeLa tubulin with 6.5% of rhodamine-labeled brain tu-
bulin and analyzed the modification state of the resulting MTs by 
immunoblot. TTLL4 induced high levels of glutamylation with 
short side chains detected with GT335, while TTLL6 mostly gen-
erated long glutamate side chains as shown with polyE antibody 
(Fig. 4 A; Fig. S2 C). Other tubulin modifications, such as de-
tyrosination and acetylation, were not altered in the differentially 
glutamylated HeLa MTs (Fig. 4 A).
To measure the efficiency of spastin-mediated severing of 
the differentially modified MTs in vitro, MTs were attached to 
mini-chambers, which were assembled as described in Materials 
and methods, and placed under the microscope. The severing   
reaction was started by flowing spastin and ATP into the cham-
bers while imaging. Within a period of 120 s, the addition of 
spastin induced disassembly of nonmodified MTs to 78.2 ± 8.5% 
Evidence favoring glutamylation as potential regulator of MT 
severing came from the observation that a mutation in a potential 
modification site on -tubulin in Caenorhabditis elegans, an   
organism without glycylation, decreased the sensitivity of MTs to 
katanin-mediated severing (Lu et al., 2004).
However, direct evidence for tubulin polyglutamylation as 
a regulator of MT severing is lacking, and it is unclear if the dif-
ferent severing enzymes are regulated by the same mechanism. 
Here, we use a set of glutamylating enzymes with different enzy-
matic specificities (van Dijk et al., 2007) to study the role of dis-
tinct MT polyglutamylation types in MT severing by a combined 
cell biology and in vitro approach.
Results and discussion
To investigate the effects of glutamylation on the interphase MT 
network, which carries very low levels of glutamylation (Regnard 
et al., 1999; Fig. S1), we expressed various polyglutamylases in 
HeLa cells to generate specific subtypes of glutamylation (van 
Dijk et al., 2007). Cells expressing glutamylases were identified 
by coexpression of CFP, and they showed strongly increased   
glutamylation on the interphase MT network (Fig. S2, A and B). 
The length of the glutamylated side chains depends on the reac-
tion specificities of the expressed enzymes (Fig. S2 C). To ad-
dress whether different types of glutamylation on MTs have 
specific functions, we first investigated two enzymes with diver-
gent enzymatic characteristics, tubulin tyrosine ligase-like pro-
teins 4 and 6 (TTLL4 and TTLL6). TTLL4 generates short side 
chains that can be detected specifically with the GT335 antibody, 
whereas TTLL6 adds long side chains detected with polyE anti-
body (Fig. S2 C). At the overexpression conditions used here, 
both enzymes modify both - and -tubulin (example in Fig. 4 A; 
van Dijk et al., 2007). Strikingly, 24 h after transfection, TTLL6-
expressing cells had lost more than 70% of their MT mass, 
whereas no changes were found after TTLL4 expression (Fig. 1, 
A and B). This effect was specific to the polyglutamylation activ-
ity and not to the presence of the TTLL6 protein because expres-
sion of an enzymatically dead version of TTLL6 had no effect 
(Fig. 1, A and B). TTLL11, another long side chain–generating 
enzyme (van Dijk et al., 2007), also reduced MT mass by more 
than 70% (Fig. 1 B), which further strengthens the conclusion 
that long glutamate side chains on tubulin provide a signal for re-
duction of MT mass.
The polyglutamylation-induced loss of interphase MTs 
was likely to be mediated by the MT-severing enzyme spastin, 
which is known to be a regulator of MT mass in metazoan cells 
(Sherwood et al., 2004). To test this, we expressed TTLL11 in 
the presence of two different siRNAs specific to spastin. While 
expression of TTLL11 alone led to the disassembly of more 
than 70% of the MTs in the cells, only 20% of the MT mass 
was lost after RNAi depletion of spastin (Fig. 1, C and D; un-
published data). This indicates that the modification of tubulin 
with long glutamate side chains induces spastin-dependent dis-
assembly of MTs in HeLa cells.
We next investigated whether exogenously expressed spas-
tin could be activated by MT polyglutamylation by using the 
most widely expressed 58-kD isoform (Fig. 1 D). To further test 947 Polyglutamylation regulates microtubule severing • Lacroix et al.
Figure 1.  Polyglutamylation induces microtubule severing in HeLa cells. (A) MT morphology in HeLa cells expressing either active TTLL6 or an inactive 
mutant (TTLL6d). Transfected cells (green contours) were identified by CFP, which was coexpressed from the same plasmid (Fig. S2). Cells were stained with 
the general tubulin antibody 12G10, which detects -tubulin in a glutamylation-independent manner (not depicted). Gray contours indicate examples of 
untransfected cells. Bar, 20 µm. (B) Quantification of MT mass in cells expressing active and inactive TTLL4, 6, and 11. Mean 12G10 fluorescence inten-
sity was measured as indicated by contours in A for >30 cells per experimental condition and plotted as normalized to the mean of nontransfected cells 
(100%). Error bars indicate SD. Statistical significance was determined by two-tailed Student’s t test. All P values (**) are below 10
10. (C) Quantification 
as in B after expression of TTLL11 in cells transfected with nonsilencing control (scramble) or spastin-specific siRNA 1720 (transfection scheme of siRNA; 
see Materials and methods). (D) Validation of spastin siRNA. HeLa cells were transfected with scramble and spastin siRNA, and actin and spastin levels 
were detected on the same blot with specific antibodies. The siRNA 1720 reduces the levels of spastin to 13.2%.JCB • VOLUME 189 • NUMBER 6 • 2010   948
(mean ± SEM) of their original lengths. In the same time frame, 
TTLL4-modified MTs were disassembled to 50.0 ± 12.7% of 
their original lengths, whereas TTLL6-modified MTs were com-
pletely severed (2.2 ± 1.7%; Fig. 4, B and C). Neither the addi-
tion of spastin in the absence of ATP nor the addition of inactive 
spastin (E439A; Fig. S3) induced severing of TTLL6-modified 
MTs, indicating the specificity of the assay (Fig. 4 C). Together 
with the observed effects of MT glutamylation in cells (Figs. 1–3), 
these in vitro data demonstrate that glutamylation of tubulin di-
rectly stimulates spastin-mediated severing of MTs, and that the 
length of the glutamate side chain determines the efficiency of 
severing. Short side chains, such as those added by TTLL4, have 
less effect than long side chains added by TTLL6. In agreement 
with these observations, brain MTs, which are highly modified 
with long glutamate side chains (Fig. 4 A), were disassembled 
within less than 20 s when assayed under similar conditions   
(unpublished data).
To test whether tubulin polyglutamylation could be a gen-
eral activator for MT-severing enzymes, we investigated another 
severing protein, katanin p60 (Hartman et al., 1998; Fig. S3). 
In contrast to spastin, katanin p60 does not localize to MTs and, 
more strikingly, it does not induce detectable MT severing upon 
expression in HeLa or U2OS cells (Fig. 5 A, panel TTLL6d + 
CFP). This made it difficult to quantify katanin activation by 
cellular MT morphology as it was done for spastin (Figs. 2  
and 3). However, expression of YFP-tagged katanin p60 to-
gether with different TTLL enzymes in U2OS cells induced   
localization of katanin p60 to MTs, which was accompanied 
by MT bundling and occasional severing (Fig. 5 A). Localization 
of katanin p60 to MTs was previously proposed as a possible 
readout for its activation (Hartman and Vale, 1999; McNally 
et al., 2000). Accordingly, two inactive mutants of katanin p60 
(E309A and E332Q; Fig. S3) were not targeted to MTs upon 
glutamylation (unpublished data). To determine the activation 
of katanin by polyglutamylation, we quantified MT localiza-
tion, bundling, and severing after coexpression of katanin p60 
with different TTLL enzymes. Similar to spastin-mediated sev-
ering, the long chain–generating glutamylase TTLL6 induced   
a more pronounced katanin p60 activation than the short side 
chain–generating enzymes TTLL4, TTLL5, and TTLL7 (Fig. 5 B). 
However, TTLL11 showed a weaker impact on katanin p60   
activation as compared with its strong effect on spastin-mediated 
severing (Figs. 1 B and 2 B). Likely explanations for these re-
sults could be that TTLL6 and TTLL11 either use different 
modification sites within the C-terminal tails of tubulin, or 
they generate glutamate side chains of different lengths. Thus,   
although spastin is insensitive to these differences, katanin 
p60 is more efficiently activated by glutamylation generated 
with TTLL6.
Figure 2.  Polyglutamylation activates 58-kD spastin in vivo. (A) HeLa cells 
were cotransfected with the 58-kD isoform of spastin-EYFP (mutated S359C; 
Fig. S3) and an active (TTLL11) or inactive (TTLL11d) polyglutamylase.   
Cells were grown for 16 h before fixation and immunofluorescence stain-
ing with 12G10. CFP allowed identification of TTLL11-expressing cells. 
Bar, 20 µm. (B) Fraction cells expressing spastin S359C-EYFP and CFP that 
show MT severing as shown in A. A minimum of 100 cells was analyzed 
in three independent experiments. Error bars indicate SD. Significance was 
determined by two-tailed Student’s t test. P values are below 0.001 (**), 
or below 0.01 (*).
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Figure 3.  Polyglutamylation activates a short version of spastin in vivo. (A) HeLa cells transfected with the N-terminally truncated form of spastin, C389-spastin-
EYFP (mutated D552N; Fig. S3), were grown for 15 h and subsequently transfected with either active TTLL11 or inactive mutant (TTLL11d) 7 h before fixation 
and immunofluorescence staining by 12G10. CFP coexpressed from the TTLL11 plasmids allowed identification of transfected cells. Bar, 20 µm. (B) Fraction of 
cells expressing C389-spastin D552N-EYFP and CFP showing MT severing (all severing phenotypes as shown in A were compiled). A minimum of 100 cells was 
analyzed in three independent experiments. Error bars SD. Significance was determined by two-tailed Student’s t test. All P values (**) are below 0.001.JCB • VOLUME 189 • NUMBER 6 • 2010   950
The  demonstration  that  long  glutamate  side  chains  are 
much more efficient at activating the MT-severing proteins spas-
tin and katanin than short side chains supports the idea that tubu-
lin modification with long glutamate side chains may be a general 
activator of MT severing. This would imply that another AAA 
MT-severing protein, fidgetin (Zhang et al., 2007), could also be 
activated by polyglutamylation. The observed differences in the 
sensitivity of spastin and katanin to TTLL11-generated poly-
glutamylation raises the exciting possibility that fine-tuning of 
these side chains could be implicated in a differential activation of 
these proteins within a single cell.
By showing that tubulin glutamylation, and in particular 
long glutamate side chains, stimulates MT severing in vivo and   
in vitro, we provide evidence that tubulin polyglutamylation can 
act as a direct regulator of MT functions. This novel regula-
tory mechanism could play a role in the local confinement of 
severing events to specific subcellular regions, or even along sin-
gle MTs. For example, the mitotic spindle shows distinct glu-
tamylation patterns on subsets of MTs, with a highly glutamylated 
midspindle, but not astral MTs (Fig. S1 A), and MTs with long 
glutamate chains restricted to the spindle poles and the midbody 
(Fig. S1 B). Polyglutamylation might thereby regulate localized 
severing  for  spindle  dynamics  and  chromosome  movement 
(McNally et al., 2006; Zhang et al., 2007), as well as for cytoki-
netic abscission (Connell et al., 2009). The relevance of poly-
glutamylation  for  ciliogenesis  and  cytoskeleton  dynamics 
during cell division is also supported by the ciliary defects and 
the cytokinesis arrests induced by mutated glutamylation/gly-
cylation sites on tubulin (Thazhath et al., 2002) and katanin 
knockout in Tetrahymena cells (Sharma et al., 2007). Another 
process that requires local MT severing and might also be reg-
ulated by the polyglutamylation status of MTs is neurite out-
growth (Ahmad et al., 1999; Wood et al., 2006).
In conclusion, MT polyglutamylation might provide a per-
missive signal within complex regulatory networks that control 
where and when MTs are severed within a single cell. How op-
posing activities of modifying (van Dijk et al., 2007) and yet 
undiscovered de-modifying enzymes control the spatial and 
temporal distribution of MT glutamylation is an important ques-
tion to be addressed in the future. Considering that mutations af-
fecting spastin activity have been linked to neurodegeneration in 
hereditary spastic paraplegia (Evans et al., 2005; Roll-Mecak and 
Vale, 2005), the discovery of polyglutamylation as a novel regu-
lator of spastin activity opens the exciting possibility that changes 
in MT glutamylation levels could play a role in the pathogenesis 
of neurodegenerative disorders.
Figure 4.  Microtubule polyglutamylation activates spastin-mediated sev-
ering in vitro. (A) Immunodetection of modification levels on purified tubu-
lin that was copolymerized with 6.5% rhodamine-labeled brain tubulin. 
GT335 detects glutamylation irrespective of the side chain length, whereas 
polyE is specific to long chains. Tubulin purified from HeLa cells differs only 
in polyglutamylation levels, while acetylation and detyrosination are not 
altered. (B) In vitro severing of differentially modified MTs. MTs purified 
from HeLa cells were copolymerized with 6.5% rhodamine-labeled brain 
tubulin and imaged over time. C389-spastin and ATP were added to the 
imaging chamber at t = 0 s. Bar, 10 µm. (C) Quantification of the relative 
length of MTs in time-lapse movies as shown in B. The total MT length was 
determined for each time frame and normalized to the first time frame 
(100% at 0 s). MT fragments <0.85 µm were omitted. Each time point rep-
resents mean ± SEM from five experiments (except for negative controls, 
which were not included in replica experiments).
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C389-spastin (C-terminal 389 amino acids; minimal version necessary 
for severing activity; White et al., 2007; Fig. S3) from mouse cDNA into 
an EYFP-tagged vector as well as into a bacterial expression vector har-
boring an N-terminal GST tag. Functionality tests showed that both versions 
of spastin are active. A truncated version of mouse KIF5B (N-terminal 555 
amino acids) was cloned with a 6-histidine (6His) tag into a bacterial 
expression vector.
Point mutations were introduced by a PCR-based quick-change 
method. The expression plasmids containing the cDNAs of the genes of in-
terest were amplified with two mutagenic primers and Pfu polymerase (Pro-
mega). Template DNA was removed by digesting with DpnI (New England 
Materials and methods
Cloning, mutagenesis, and siRNA
The cloning of mouse TTLL4, 5, 6, 7, and 11 has been described previ-
ously (van Dijk et al., 2007). Untagged TTLL proteins were expressed under 
the control of the cytomegalovirus promoter, together with CFP, which 
was under the control of a second cytomegalovirus promoter on the same 
expression plasmid (see Fig. S2 for functionality tests of these vectors). 
Katanin p60 was cloned from mouse cDNA into an EYFP-tagged vector. 
For spastin, we cloned the most widely expressed 58-kD isoform of 
spastin  (starting  at  position  85;  Fig.  S3),  and  the  truncated  version 
Figure  5.  Effects  of  differential  microtubule 
glutamylation on katanin p60. (A) U2OS cells 
were  cotransfected  with  katanin  p60-EYFP 
and either active TTLL6 or an inactive mutant 
(TTLL6d), with CFP as transfection control. Ac-
tivation of katanin leads to MT localization of 
katanin p60, and sometimes to MT bundling 
and/or severing. Bar, 20 µm. (B) Fraction 
of  cells  showing  colocalization  of  katanin   
p60-EYFP with MTs (all phenotypes as shown 
in A were compiled). A minimum of 200 cells 
was  analyzed  in  three  independent  experi-
ments. Error bars indicate SD.JCB • VOLUME 189 • NUMBER 6 • 2010   952
Biolabs, Inc.) for 4 h at 37°C; the DNA was then transformed into Esche-
richia coli cells and single clones were isolated. The presence of the muta-
tion was verified by DNA sequencing. Using this method, we generated 
two previously described inactive versions for each of katanin p60 and 
spastin (see Fig. S3 for details). Additionally, we generated spastin ver-
sions with reduced activity, carrying the S359C (C1076G) or the D552N 
(G1654A)  mutation  (Fonknechten  et  al.,  2000;  Roll-Mecak  and  Vale, 
2005; Fig. S3). The Walker motif of KIF5B was mutated T92N to gain a 
nonmotile  kinesin  (C275A;  Nakata  and  Hirokawa,  1995),  which  was 
used to fix MTs onto glass slides in the in vitro experiments.
Two siRNAs for spastin, siRNA 1720 (GCCAGUGAGAUGAGA-
AAUA; Fig. 1 D) and siRNA 623 (AAACGGACGUCUAUAAUGA; Connell 
et al., 2009; not depicted) were used in our assays.
Purification of recombinant proteins
Recombinant proteins produced in E. coli were fused to either 6His or GST. 
The cells were grown at 37°C into the exponential growth phase, then 
cooled down to 20°C, and protein production was induced with 0.5 mM 
IPTG. Cells were harvested after 4 h.
For purification of GST-tagged C389-spastin, bacteria were resus-
pended in lysis buffer (20 mM Tris/HCl, pH 7.5, 300 mM NaCl, 2 mM 
MgCl2, 1 mM ATP, and protease inhibitors) and sonicated. The lysate was 
centrifuged at 80,000 g for 10 min at 4°C. The supernatant was incubated 
with glutathione sepharose (GE Healthcare) for 30 min at 4°C. The flow-
through was discarded and the resin washed with wash buffer (20 mM 
Tris/HCl, pH 7.5, and 500 mM NaCl) until the flow-through was clear of 
protein. GST fusion proteins were eluted with elution buffer (50 mM Tris/
HCl, pH 8.0, 300 mM NaCl, 10 mM MgCl2, 5 mM DTT, and 20 mM re-
duced  glutathione).  After  purification,  GST-C389-spastin  was  dialyzed 
against Hepes buffer (20 mM Hepes/NaOH, pH 7.5, 100 mM NaCl, 3 mM 
MgCl2, and 5 mM DTT).
To isolate 6His-tagged KIF5B, bacteria were resuspended in lysis buf-
fer (20 mM potassium phosphate, pH 7.0, 150 mM NaCl, 1 mM MgCl2, 
0.1 mM ATP, 5 mM -mercaptoethanol, 10% [wt/vol] glycerol, and protease 
inhibitors) and sonicated. The lysate was centrifuged at 80,000 g for 10 min 
at 4°C. In parallel, chelating sepharose (GE Healthcare) resin was incubated 
for 5 min with 4 volumes of 200 mM NiSO4 and subsequently equilibrated 
with equilibration buffer (50 mM potassium phosphate, pH 7.0, and 100 mM 
NaCl). The clarified supernatant was then incubated with the resin for 30 min 
at 4°C. The flow-through was discarded and the resin washed with wash 
buffer (50 mM potassium phosphate, pH 7.0, 1 M NaCl, 2 mM -mercapto-
ethanol, 25 mM imidazole, and 10% [wt/vol] glycerol) until the flow-through 
was clear of protein. The 6His-tagged protein was eluted with elution buffer 
(150 mM imidazole, 50 mM KCl, 10 mM -mercaptoethanol, and 10% 
[wt/vol] glycerol). After purification, KIF5B was concentrated and dialyzed 
with motor buffer (12 mM Pipes, pH 7.0, 10 mM NaCl, 1 mM EGTA, and 
1 mM MgCl2).
Tubulin purification (detailed protocol: Lacroix and Janke, 2010)
Tubulin was purified from HeLa cells grown in adherent culture. The purifica-
tion protocol was adapted from a method for yeast tubulin purification (Davis 
et al., 1993). For the induction of tubulin glutamylation, cells were trans-
fected with either TTLL4_C639-EYFP for the generation of short glutamate 
side chains, or TTLL6_N513-EYFP for long chains. (The truncated versions of 
TTLLs have been shown to be expressed at higher levels and to be more ac-
tive. Both enzymes modify - as well as -tubulin under the experimental 
conditions used here; van Dijk et al., 2007).
Purification experiments were performed with 1 g of cultured cells. 
Cells were detached from the culture dishes with PBS containing 0.5 mM 
of EDTA, collected and spun down (200 g for 5 min at 22°C). Cells were 
lysed (2 ml buffer for 1 g of cells) on ice in MEM buffer (50 mM MES/
NaOH, pH 6.8, 2 mM EGTA, 1 mM MgCl2, and 0.2% [vol/vol] NP-40) 
containing 200 mM NaCl. The soluble fraction was obtained by centrifu-
gation at 120,000 g for 10 min at 4°C, and directly loaded onto a DEAE 
fast-flow sepharose (GE Healthcare) column (2 ml) at 1 ml/min. The column 
was washed with MEM buffer with 200 mM NaCl at the same flow rate 
until no protein was detected in the flow-through. Tubulin was eluted with 
an NaCl gradient (200–520 mM NaCl in MEM buffer, gradient volume: 
40 ml). The eluted fractions were analyzed by SDS-PAGE followed by 
Coomassie brilliant blue staining of the proteins, and the fractions with the 
purest and most concentrated tubulin were pooled and precipitated with 
60% (wt/vol) ammonium sulfate at 4°C for 20 min. The pellet was dis-
solved in 500 µl BRB80 buffer (80 mM Pipes/NaOH, pH 6.9, 1 mM 
EGTA, and 1 mM MgCl2) containing 0.1 mM GTP, and cleaned up on a 
NAP-5 gel filtration column (GE Healthcare) with BRB80 buffer containing 
0.1 mM GTP. The tubulin purified in this way was ready for polymerization, 
and could also be frozen in liquid nitrogen and stored at 80°C. From 
1 g of cells, 400 µg of protein was obtained. Although the purified 
HeLa tubulin was of high purity, we cannot exclude the possibility that 
trace amounts of other proteins that were copurified (for details see Lacroix 
and Janke, 2010) had an influence on the severing activity measured in 
our assays.
In vitro MT-severing assay (Fig. 4 , B and C)
100 µl of 1 mg/ml HeLa tubulin were polymerized into MTs for 30 min at 
37°C in BRB80 buffer, containing 4 µM Paclitaxel, 1 µl of 7 mg/ml rhodamine- 
labeled tubulin (Hyman et al., 1991), and 5 µl of 25 mM GTP. Finally, the 
MTs were stabilized with 20 µM Paclitaxel, and the MT solution was kept   
in the dark. To avoid the possibility of the incorporated rhodamine-labeled 
tubulin biasing the experimental results, the same amounts were copolymer-
ized with each batch of HeLa tubulin.
Mini-chambers were prepared on glass slides that were previously 
treated with hot ethanol steam. The chambers were kept on ice during prepa-
ration. After two washes with motor buffer (12 mM Pipes/NaOH, pH 7.0, 
10 mM NaCl, 1 mM EGTA, and 1 mM MgCl2), a 0.25-mg/ml solution of 
purified KIF5B 555 T92N motor was perfused twice and incubated for 8 min 
on ice. The kinesin-coated chambers were transferred to room temperature 
and incubated for 2 min before washing three times with Hepes buffer (20 mM 
Hepes/NaOH, pH 7.5, 100 mM NaCl, and 3 mM MgCl2). The MT solution 
at 15 µg/ml was then twice perfused into the chambers, which were then in-
cubated for 5 min at room temperature in the dark to allow the MTs to attach 
to the kinesin.
The chambers were washed four times with Hepes buffer and then 
transferred to an upright fluorescence microscope (DMRA, Leica) with a 
100× immersion objective at 23°C. The focus and light intensity were ad-
justed to the rhodamine-labeled MTs. The chambers were perfused twice 
with severing buffer (20 mM Hepes/NaOH, pH 7.5, 100 mM NaCl, 3 mM 
MgCl2, 10 mM DTT, 1 mM ATP, 20 mM glucose, 0.4 mg/ml glucose oxi-
dase, and 0.2 mg/ml catalase) containing 1 µM purified GST-C389-spastin, 
and the image acquisition was started immediately with a time lapse of 40 s 
for a total duration of 2 min (Fig. 4 B).
The total MT length of each movie frame was measured manually by 
drawing a straight line over each MT using ImageJ software (open source 
http://rsbweb.nih.gov/ij). Fluorescent particles smaller than 0.85 µm were 
excluded from quantification. The MT length of each movie frame was nor-
malized to t = 0 s.
Measurement of MT disassembly in cells (Fig. 1, B and C)
HeLa cells transfected with TTLL-encoding plasmids were identified by co-
expressed CFP. Cells were fixed and tubulin was visualized using the 12G10 
antibody. Images were acquired using the same settings for all slides, and 
analyzed in ImageJ software. On each slide, at least 30 CFP-positive cells, 
as well as 30 control cells without CFP expression, were analyzed by man-
ual definition of cell contours and measurement of mean tubulin fluores-
cence. Mean and standard deviations were then determined for the cell 
population of each condition, and then normalized to nontransfected cells. 
Significant deviations were tested by two-tailed Student’s t test at a signifi-
cance level of P ≤ 0.001.
Protein electrophoresis and immunoblot
SDS-PAGE was performed using standard protocols, or in the case of 
mammalian - and -tubulin by a special protocol, as in Eddé et al., 
1987. Proteins were transferred to nitrocellulose or PVDF membranes 
(GE Healthcare) and detected with antibodies. Membranes were incubated 
with rabbit polyE (anti-polyglutamylation; 1:1,000) and anti-detyrosinated 
tubulin (1:1,000; Millipore) antibodies, or mouse GT335 (anti-glutamylation, 
1:1,000; Wolff et al., 1992), 6-11B-1 (anti-acetylated tubulin; 1:2,000; 
Sigma-Aldrich), anti-actin clone C4 (1:200,000; Millipore), Sp 3G11/1 
(anti-spastin; 1:200; Santa Cruz Biotechnology, Inc.), and 12G10 (anti-
-tubulin; 1:500). Protein bands were visualized with HRP-labeled donkey 
anti–rabbit or anti–mouse IgG (1:10,000; GE Healthcare) followed by 
detection with chemiluminescence (ECL Western blot detection kit; GE 
Healthcare). Protein bands were quantified (Fig. 1 D) using the Chemi-
Glow  West  ECL  kit  and  the  sFluorchem  chemiluminescence  imager   
(Alpha Innotech).
Cell culture, immunofluorescence, and microscopy
HeLa or U2OS cells were cultured on plastic dishes or glass coverslips 
under standard conditions. Expression plasmids were transfected using JetPEI 
(Polyplus transfection), and siRNA with Oligofectamine (Invitrogen). For 
siRNA treatment, cells were transfected with siRNA and grown for 24 h 
before plasmids were transfected. A second siRNA transfection was 953 Polyglutamylation regulates microtubule severing • Lacroix et al.
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performed 2 h after the transfection of the DNA plasmid, and cells were 
analyzed 22 h later (Fig. 1, C and D).
Cells were fixed using a protocol for the preservation of cytoskeletal 
structures (Bell and Safiejko-Mroczka, 1995) and then incubated with polyE 
(1:1,500), GT335 (1:5,000), 12G10 (1:500), the rabbit anti-tubulin C105 
(1:1,000; gift of M. Andreu, Centro de Investigaciones Biológicas, Madrid, 
Spain) antibodies for 1 h, followed by 30 min with anti–mouse or anti–rabbit 
Alexa 568, or anti–mouse or anti–rabbit Alexa 488 antibody (1:1,000; In-
vitrogen). DNA was visualized by DAPI staining (0.02 µg/ml). Coverslips 
were mounted with Mowiol polyvinyl alcohol 4-88 (Fluka). We used DMRA 
microscopes (Leica) at 23°C with the oil objectives 40× (NA 1.25), 63× 
(NA 1.32), and 100× (NA 1.4). For the imaging of the MT cytoskeleton, the 
mechanical aperture of the objectives was closed in order to have an in- 
focus representation of the whole MT network. The fluorochromes imaged 
were DAPI (filter: excitation 340–380 nm, emission 425 nm; Leica), ECFP 
(excitation 421–450 nm, emission 466–500 nm; Chroma Technology 
Corp.) Alexa 488 (excitation 450–490 nm, emission 500–550 nm; Leica), 
EYFP (excitation 482–512 nm, emission 532–568 nm; Chroma Technology 
Corp.), and Alexa 555 and 568 (excitation 530–560 nm, emission 572.5–
647.5 nm; Leica). Images were acquired using a CoolSnap HQ camera 
(Photometrics) and MetaMorph 7 software (MDS Analytical Technologies). 
Images were analyzed using ImageJ software and assembled in Adobe 
Photoshop (Adobe Systems, Inc.).
Online supplemental material
Fig. S1 shows the distribution of glutamylated and polyglutamylated MTs in 
HeLa cells during the cell cycle. Fig. S2 shows a functionality and specificity 
test for expression vectors that express TTLL proteins and CFP separately.   
Fig. S3 shows annotated alignment of the protein sequences of mouse spas-
tin and katanin p60. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201001024/DC1.
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